CHS Dream of a Cure Research Grants
CHS Dream of a Cure Research Grants support researchers studying bleeding disorders through basic scientific research to develop treatments, improve health and quality of life, and ultimately find a cure.
Funder: Bleeding Disorders Canada (formerly Canadian Hemophilia Society)
Due Dates: November 27, 2026 (Application deadline)
Funding Amounts: $75,000 per year per project, maximum $150,000 over 2 or 3 years
Summary: Supports basic scientific research on bleeding disorders to improve health and quality of life and ultimately find a cure.
Key Information: Applicants must be Canadian citizens or permanent residents affiliated with a Canadian university or not-for-profit health-related organization.
Description
Bleeding Disorders Canada, formerly the Canadian Hemophilia Society (CHS), administers Dream of a Cure Research Grants with support from the Hemophilia Research Million Dollar Club and the Society. The program funds basic scientific research aimed at improving the health and quality of life of people with inherited bleeding disorders, developing treatments, and ultimately finding a cure.
Relevant research includes hemophilia A and B, von Willebrand disease, rare factor deficiencies, platelet function disorders and platelet pathophysiology, and other congenital and acquired bleeding disorders. These awards support research projects rather than the separate Summer Studentships program. The organization changed its name in July 2026, so application documents may use either name during the transition.
